These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 12421238

  • 1. Preliminary evaluation of soluble IL-2 receptor and type III procollagen N-terminal aminopeptide in pleural fluid for differentiating tuberculous, carcinomatous and parapneumonic pleural effusions.
    Harita S, Nogami N, Kikuchi T, Kibata M.
    Respirology; 2002 Dec; 7(4):311-5. PubMed ID: 12421238
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of soluble interleukin 2 receptor in differentiating tuberculous and carcinomatous pleural effusions.
    Chang SC, Hsu YT, Chen YC, Lin CY.
    Arch Intern Med; 1994 May 23; 154(10):1097-101. PubMed ID: 8185423
    [Abstract] [Full Text] [Related]

  • 3. [Type III procollagen N-terminal aminopeptide and type IV collagen 7S in pleural effusion fluid].
    Tsuchiya Y, Nishikawa M, Iwamoto K, Kirioka T, Noguchi M, Watanabe A, Nishiwaki K, Nozaki Y, Nakane Y.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun 23; 35(6):622-6. PubMed ID: 9294295
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis of tuberculous pleuritis by the measurement of soluble interleukin 2 receptor in pleural fluid.
    Porcel JM, Gázquez I, Vives M, Pérez B, Rubio M, Rivas MC.
    Int J Tuberc Lung Dis; 2000 Oct 23; 4(10):975-9. PubMed ID: 11055766
    [Abstract] [Full Text] [Related]

  • 5. Pleural fluid and serum soluble interleukin-2 receptors in pleural effusions.
    Sarandakou A, Poulakis N, Rizos D, Phocas I.
    Anticancer Res; 1991 Oct 23; 11(3):1365-8. PubMed ID: 1888173
    [Abstract] [Full Text] [Related]

  • 6. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions.
    Hara N, Abe M, Inuzuka S, Kawarada Y, Shigematsu N.
    Chest; 1992 Oct 23; 102(4):1060-4. PubMed ID: 1395743
    [Abstract] [Full Text] [Related]

  • 7. [Clinical significance of soluble interleukin 2 receptor alpha in the pleural fluid].
    Ni SS, Gao ZL.
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb 23; 16(2):81-2, 123. PubMed ID: 8221956
    [Abstract] [Full Text] [Related]

  • 8. [Elevated soluble interleukin-2 receptor and interleukin-2 receptor positive cells in carcinomatous pleural effusions].
    Kojiro N, Moriwaki Y, Ito M, Nishiki M, Shirasaka T, Kokubu T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan 23; 28(1):100-4. PubMed ID: 2355670
    [Abstract] [Full Text] [Related]

  • 9. [Comparative study of soluble interleukin 2 receptor and adenosine deaminase levels in tuberculous and other etiologies pleural fluids].
    Avilés Inglés MJ, Contessotto C, Ontañón J, Muro M, Berlinches P, de la Torre J, Sánchez Gascón F, Alvarez López MR.
    Arch Bronconeumol; 1996 Dec 23; 32(10):523-6. PubMed ID: 9019312
    [Abstract] [Full Text] [Related]

  • 10. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS, Kostikas K, Oikonomidi S, Tsilioni I, Nikoulis D, Germenis A, Gourgoulianis KI.
    Respir Med; 2007 May 23; 101(5):910-8. PubMed ID: 17270413
    [Abstract] [Full Text] [Related]

  • 11. Serum and pleural fluid N-Terminal-Pro-B-Type natriuretic peptide concentrations in the differential diagnosis of pleural effusions.
    Yorgancıoğlu A, Ozgen Alpaydın A, Yaman N, Taneli F, Bayturan O, Sakar Coşkun A, Celik P.
    Tuberk Toraks; 2011 May 23; 59(1):1-7. PubMed ID: 21554224
    [Abstract] [Full Text] [Related]

  • 12. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
    Liu CL, Hsieh WY, Wu CL, Kuo HT, Lu YT.
    Respir Med; 2007 May 23; 101(5):903-9. PubMed ID: 17097866
    [Abstract] [Full Text] [Related]

  • 13. Neopterin, soluble interleukin-2 receptor and adenosine deaminase levels in pleural effusions.
    Chiang CS, Chiang CD, Lin JW, Huang PL, Chu JJ.
    Respiration; 1994 May 23; 61(3):150-4. PubMed ID: 8047718
    [Abstract] [Full Text] [Related]

  • 14. Are soluble IL-2 receptor and IL-12p40 levels useful markers for diagnosis of tuberculous pleurisy?
    Tural Önür S, Sökücü SN, Dalar L, Seyhan EC, Akbaş A, Altin S.
    Infect Dis (Lond); 2015 Mar 23; 47(3):150-5. PubMed ID: 25549699
    [Abstract] [Full Text] [Related]

  • 15. [Contribution of pleural fluid analysis to the diagnosis of pleural effusion].
    Ferreiro L, Toubes ME, Valdés L.
    Med Clin (Barc); 2015 Aug 21; 145(4):171-7. PubMed ID: 25433793
    [Abstract] [Full Text] [Related]

  • 16. The etiology of pleural effusions in an area with high incidence of tuberculosis.
    Valdés L, Alvarez D, Valle JM, Pose A, San José E.
    Chest; 1996 Jan 21; 109(1):158-62. PubMed ID: 8549179
    [Abstract] [Full Text] [Related]

  • 17. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
    Lee SH, Lee EJ, Min KH, Hur GY, Lee SY, Kim JH, Shin C, Shim JJ, In KH, Kang KH, Lee SY.
    Clin Biochem; 2013 Oct 21; 46(15):1484-8. PubMed ID: 23570862
    [Abstract] [Full Text] [Related]

  • 18. Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions.
    Wang M, Zhang Z, Wang X.
    Clinics (Sao Paulo); 2014 Oct 21; 69(12):799-803. PubMed ID: 25627990
    [Abstract] [Full Text] [Related]

  • 19. IL-8 in pleural effusion.
    Ceyhan BB, Ozgün S, Celikel T, Yalçin M, Koç M.
    Respir Med; 1996 Apr 21; 90(4):215-21. PubMed ID: 8736655
    [Abstract] [Full Text] [Related]

  • 20. Development and Validation of the COMPLES Score for Differentiating Between Tuberculous Effusions with Low Pleural pH or Glucose and Complicated Parapneumonic Effusions.
    Corral-Gudino L, García-Zamalloa A, Prada-González C, Bielsa S, Alexis D, Taboada-Gómez J, Dos-Santos-Gallego PR, Alonso-Fernández MA, Porcel JM.
    Lung; 2016 Oct 21; 194(5):847-54. PubMed ID: 27401009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.